Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Use of NovoSeven® in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis

NCT00154492 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00154492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00154492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Use of NovoSeven® in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
August 31, 2006
Enrollment
265 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

acquired bleeding disorder, cirrhosis